Denmark· DK-28107028323
Emblaveo
A aztreonam und beta-lactamase-inhibitor product containing avibactamnatrium, aztreonam, registered in Denmark by Pfizer Europe MA EEIG. The same ATC class is registered in 7 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Aztreonam und beta-lactamase-inhibitor is registered in 7 of 19 countries.
Countries holding a registration under ATC J01DF51 (aztreonam und beta-lactamase-inhibitor), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 4 of them publish a price we can compare per daily dose
Aztreonam und beta-lactamase-inhibitor · ATC J01DF51
7 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Ireland
- Netherlands
- Norwayprice
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- Avibactamnatrium, AZTREONAM
- Manufacturer
- Pfizer Europe MA EEIG
- Country
- Denmark (DK)
- ATC code
- J01DF51
- ATC class
- Aztreonam und Beta-Lactamase-Inhibitor
- Defined daily dose
- 6 g, P
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28107028323
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under J01DF51
Aztreonam und beta-lactamase-inhibitor, as other registers publish it.
- FinlandEmblaveoPfizer Europe MA EEIG
- NorwayEmblaveoPfizer Europe MA EEIG
- CzechiaEMBLAVEOPfizer Europe MA EEIG, Bruxelles
- NetherlandsEmblaveo 1,5 g/0,5 g poeder voor concentraat voor oplossing voor infusiePfizer Europe MA EEIG
- BelgiumEmblaveo 1.5 g - 0.5 gPfizer Europe MA
- IrelandEmblaveo 1.5 g/0.5 g powder for concentrate for solution for infusionPfizer Europe MA EEIG
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e75e99d3-038a-4944-9cf9-107758719870 GET /v1/drugs/e75e99d3-038a-4944-9cf9-107758719870?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "pulver til koncentrat til infusionsvæske, opløsning",
"source": "dkma",
"strength": "1,5/0,5 g",
"auth_role": "MOD",
"dk_drugid": "28107028323",
"substance": "Avibactamnatrium, AZTREONAM",
"auth_procedure": "Central",
"in_medicinpriser": true,
"registration_date_serial": "45404"
}See everything about aztreonam und beta-lactamase-inhibitor.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.